Pharmaron
300759.SZPharmaron Beijing Co., Ltd. Price (300759.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
1,775,257,234
(0.0544)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Pharmaron Beijing Co., Ltd.Currency: CNY
| YEAR | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
790.44M
+0% |
1.13B
+43% |
1.63B
+45% |
2.29B
+40% |
2.91B
+27% |
3.76B
+29% |
5.13B
+37% |
7.44B
+45% |
10.27B
+38% |
11.54B
+12% |
|||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 592.09M | 817.64M | 1.16B | 1.54B | 1.96B | 2.42B | 3.21B | 4.76B | 6.50B | 7.42B | |||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
198.35M
+0% |
310.40M
+56% |
474.01M
+53% |
751.01M
+58% |
944.67M
+26% |
1.33B
+41% |
1.92B
+44% |
2.68B
+39% |
3.77B
+41% |
4.12B
+9% |
|||||||||
| Gross Profit Ratio | (0.25%) | (0.28%) | (0.29%) | (0.33%) | (0.32%) | (0.36%) | (0.37%) | (0.36%) | (0.37%) | (0.36%) | |||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 0.00 | 0.00 | 16.44M | 22.61M | 31.61M | 62.87M | 105.35M | 151.77M | 282.32M | 448.28M | |||||||||
| General and Administrative | 143.39M | 112.07M | 123.50M | 127.24M | 128.23M | 222.42M | 295.64M | 254.82M | 739.42M | 1.61B | |||||||||
| Selling, General & Admin... | 155.26M | 128.50M | 155.53M | 174.40M | 182.88M | 295.41M | 388.28M | 410.44M | 969.49M | 1.90B | |||||||||
| Selling & Marketing Exp... | 11.86M | 16.44M | 32.04M | 47.16M | 54.66M | 72.99M | 92.64M | 155.62M | 230.07M | 252.78M | |||||||||
| Depreciation and Amortiz... | 51.26M | 63.69M | 150.10M | 232.67M | 315.88M | 373.77M | 437.20M | 577.67M | 766.06M | 1.01B | |||||||||
| Other Expenses | 6.05M | 14.60M | 24.67M | 15.55M | 20.46M | 271.96M | 345.31M | 591.84M | 766.00M | -75,474,824.00 | |||||||||
| Total Operating Expenses | 156.87M | 224.98M | 286.00M | 388.85M | 503.53M | 630.23M | 838.94M | 1.15B | 2.02B | 2.27B | |||||||||
| Cost and Exponses | 748.96M | 1.04B | 1.45B | 1.93B | 2.47B | 3.05B | 4.05B | 5.92B | 8.52B | 9.69B | |||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
24.61M
+0% |
72.91M
+196% |
189.84M
+160% |
262.97M
+39% |
380.05M
+45% |
631.49M
+66% |
1.32B
+110% |
1.91B
+45% |
1.69B
-12% |
1.85B
+9% |
|||||||||
| Operating Income Ratio | (0.03%) | (0.06%) | (0.12%) | (0.11%) | (0.13%) | (0.17%) | (0.26%) | (0.26%) | (0.16%) | (0.16%) | |||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 0.00 | 1.17M | 1.79M | 376.57k | 367.98k | 9.61M | 74.06M | 64.41M | 35.21M | 29.93M | |||||||||
| Interest Expenses | 13.78M | 17.06M | 17.48M | 60.30M | 71.62M | 82.48M | 23.85M | 83.07M | 167.31M | 182.19M | |||||||||
| Total Other Income/Exp... | 4.29M | 14.60M | 24.67M | 15.55M | -15,780.00 | 1.06M | -4,465,125.00 | -3,341,785.00 | -23,500,412.00 | -10,005,288.00 | |||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 92.74M | 149.11M | 324.87M | 486.94M | 700.55M | 1.03B | 1.81B | 2.50B | 2.63B | 3.03B | |||||||||
| EBITDA ratio | (0.12%) | (0.15%) | (0.20%) | (0.21%) | (0.24%) | (0.27%) | (0.32%) | (0.35%) | (0.25%) | (0.26%) | |||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 28.91M | 87.51M | 214.51M | 278.52M | 400.51M | 632.55M | 1.32B | 1.91B | 1.67B | 1.84B | |||||||||
| Income Before Tax Ratio | (0.04%) | (0.08%) | (0.13%) | (0.12%) | (0.14%) | (0.17%) | (0.26%) | (0.26%) | (0.16%) | (0.16%) | |||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 7.91M | 13.67M | 37.60M | 51.49M | 61.48M | 101.88M | 172.38M | 290.92M | 314.25M | 256.11M | |||||||||
| Net Income | |||||||||||||||||||
| Net Income | 21.00M
+0% |
73.85M
+252% |
176.91M
+140% |
230.86M
+30% |
339.22M
+47% |
547.19M
+61% |
1.17B
+114% |
1.66B
+42% |
1.37B
-17% |
1.60B
+16% |
|||||||||
| Net Income Ratio | (0.03%) | (0.07%) | (0.11%) | (0.10%) | (0.12%) | (0.15%) | (0.23%) | (0.22%) | (0.13%) | (0.14%) | |||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.04 | 0.38 | 0.23 | 0.26 | 0.38 | 0.37 | 0.66 | 0.93 | 0.78 | 0.90 | |||||||||
| Diluted EPS | 0.04 | 0.38 | 0.23 | 0.26 | 0.38 | 0.37 | 0.66 | 0.91 | 0.77 | 0.90 | |||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 505.46M | 505.46M | 758.19M | 887.91M | 886.07M | 1.49B | 1.78B | 1.78B | 1.77B | 1.78B | |||||||||
| Diluted Share Outstanding | 505.46M | 505.46M | 758.19M | 887.91M | 886.07M | 1.49B | 1.78B | 1.81B | 1.78B | 1.78B | |||||||||